19/01/2013 00:27:00

Johnson & Johnson in Talks for Hip Implant Settlement -Bloomberg

Related content
13 Oct - 
Fundamental Equity Analysis – Consolidated Research on ..

Johnson & Johnson (JNJ) is in talks to settle litigation over recalled hip implants, Bloomberg News reported Friday, citing five people familiar with the matter.

The settlement could total more than $2 billion if most plaintiffs accept the terms, Bloomberg reported.

According to the report, J&J has offered to pay more than $200,000 per case, while lawyers for plaintiffs have said the offer is too low.

Full story at http://www.bloomberg.com/news/2013-01-18/j-j-said-to-offer-implant-pact-that-may-reach-2-billion.html

Write to nymonitoring@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

January 18, 2013 19:27 ET (00:27 GMT)

Copyright (c) 2013 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Majedie Asset Management Ltd : Form 8.3 - TESCO PLC

21/11/2017 15:35:27
FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: ..

Alliance Trust PLC : Net Asset Value(s)

21/11/2017 13:37:22
ALLIANCE TRUST PLC                                    At the close of business on Monday 20 November 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 778.0p -       including income, 787.7p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding inc..

Admiral Group PLC : Holding(s) in Company

21/11/2017 10:20:10
TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Genmab Announces European Regulatory Submission for Daratumumab in Front Line Multiple Myeloma
2
ARRAY BIOPHARMA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm
3
Lands’ End Names Gill Hong Executive Vice President, Chief Merchandising Officer and Head of International; Names Sarah Rasmusen Senior Vice President of E-Commerce
4
Sprouts Farmers Market to Present at the Barclays 2017 Eat, Sleep, Play – It’s Not All Discretionary Conference
5
Newtek Technology Solutions Joins the VMware Cloud Provider™ Program

Related stock quotes

Johnson & Johnson 138.34 0.0% Stock price unchanged

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 November 2017 10:38:35
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20171108.1 - EUROWEB6 - 2017-11-22 11:38:35 - 2017-11-22 10:38:35 - 1000 - Website: OKAY